Your session is about to expire
← Back to Search
Microaggression Impact Assessment for Smoking Behavior
N/A
Recruiting
Led By Brooke Y Kauffman, Ph.D.
Research Sponsored by University of Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Being 18 years of age or older
Current regular (daily) cigarette smoking for >= 1 year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the smoking as usual visit and smoking deprivation visit (visits are randomly ordered, counterbalanced separated by ~14 days)
Awards & highlights
No Placebo-Only Group
Summary
This trial examines the correlation between microaggressions and smoking habits, withdrawal symptoms, and cravings. It also investigates whether smoking deprivation affects the relationship between microaggressions and these aspects of smoking behavior.
Who is the study for?
This trial is for Hispanic or Latino adults who smoke at least 5 cigarettes a day, have been smoking regularly for over a year, and have experienced microaggressions in the past 6 months. Participants must be at least 18 years old and able to give informed consent. Those with active suicidal thoughts cannot join.
What is being tested?
The study investigates how experiencing microaggressions might affect smoking behavior, withdrawal symptoms, and cravings among Latinx smokers. It also looks into whether not smoking for a while changes these effects.
What are the potential side effects?
Since this trial involves psychological tasks rather than medical interventions, traditional side effects like those seen with medications are not expected. However, participants may experience stress or discomfort when recalling experiences of racial discrimination.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
You have been smoking cigarettes every day for at least one year.
Select...
You identify yourself as Hispanic or Latino.
Select...
I have experienced at least one microaggression in the last 6 months.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during the smoking as usual visit and smoking deprivation visit (visits are randomly ordered, counterbalanced separated by ~14 days)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the smoking as usual visit and smoking deprivation visit (visits are randomly ordered, counterbalanced separated by ~14 days)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Smoking Behaviors
Smoking Lapse Behaviors
Subjective Withdrawal
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Smoking as UsualExperimental Treatment1 Intervention
Smoking as usual prior to experimental visit.
Group II: Smoking DeprivationExperimental Treatment1 Intervention
16 hours of smoking abstinence prior to experimental visit.
Find a Location
Who is running the clinical trial?
University of HoustonLead Sponsor
151 Previous Clinical Trials
47,843 Total Patients Enrolled
5 Trials studying Smoking
474 Patients Enrolled for Smoking
Brooke Y Kauffman, Ph.D.Principal InvestigatorUniversity of Houston
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You consider yourself to be of Hispanic or Latino ethnicity.You identify yourself as Hispanic or Latino.I am 18 years old or older.I am 18 years old or older.You have been smoking cigarettes daily for at least one year.You are currently experiencing suicidal thoughts or have plans to harm yourself.I have experienced at least one microaggression in the last 6 months.I have experienced at least one microaggression in the last 6 months.You have been smoking cigarettes every day for at least one year.
Research Study Groups:
This trial has the following groups:- Group 1: Smoking as Usual
- Group 2: Smoking Deprivation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Smoking Patient Testimony for trial: Trial Name: NCT05490927 — N/A